Skip to main content
. 2020 Apr 20;21(8):2877. doi: 10.3390/ijms21082877

Table 1.

Summary of the adverse, neutral, and beneficial effects of melatonin in rheumatoid arthritis.

Adverse/Neutral/Beneficial Sample/Animal Model/Cell Line Melatonin Level Effects References
Adverse CIA mice graphic file with name ijms-21-02877-i001.jpg RA graphic file with name ijms-21-02877-i001.jpg [40]
Adverse CIA mice (pinealectomy) graphic file with name ijms-21-02877-i002.jpg Serum anti-CII
RA
graphic file with name ijms-21-02877-i002.jpg [41]
Adverse RA synovial macrophages/myeloid monocytic cells (THP-1) graphic file with name ijms-21-02877-i001.jpg IL-12
NO

Inline graphic
[33]
Adverse CIA rats graphic file with name ijms-21-02877-i001.jpg Anti-collagen antibodies
IL-1β and IL-6
graphic file with name ijms-21-02877-i001.jpg [32]
Neutral Treatment with melatonin Erythrocyte sedimentation rate (ESR) and neopterin graphic file with name ijms-21-02877-i001.jpg [35]
Neutral RA patients’ plasma levels graphic file with name ijms-21-02877-i001.jpg [36]
Beneficial Treatment with melatonin MMP-9 graphic file with name ijms-21-02877-i002.jpg [46]
Beneficial Fibroblast-like synoviocytes (FLS) Treatment with melatonin P21/P27
FLS proliferation
Inline graphic Inline graphic [48]
Beneficial Synovial fibroblasts Treatment with melatonin miR-3150a-3p
IL-1β and TNF-α
Inline graphic Inline graphic [20]
Beneficial Treatment with melatonin TLR/MAPK
Nrf2
Inline graphic Inline graphic [15]
Beneficial Treatment with melatonin ROS and RNS
glutathione and antioxidant enzymes
Inline graphic Inline graphic [28]
Beneficial Osteoblast cells Treatment with melatonin miR-590-3p
Apoptosis
Inline graphic Inline graphic [55]